XML 22 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Interim Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Retained Earnings [Member]
Beginning Balance at Dec. 31, 2019 $ 126,459 $ 98,333 $ 4,351 $ (475) $ 24,250
Beggining Balance (in shares) at Dec. 31, 2019   52,657,000      
Shares issued in public offering, net of issuance costs 42,569 $ 42,569      
Shares issued in pubic offering, net of issuance costs (in shares)   12,990,000      
Warrants issued in public offering 11,369   11,369    
Shares issued on exercise of stock options 251 $ 408 (157)    
Shares issued on exercise of stock options (in shares)   313,000      
Share-based compensation 1,329   1,329    
Cumulative translation adjustment (41)     (41)  
Net income (loss) 4,591       4,591
Ending Balance at Sep. 30, 2020 186,527 $ 141,310 16,892 (516) 28,841
Ending Balance (in shares) at Sep. 30, 2020   65,960,000      
Beginning Balance at Dec. 31, 2019 126,459 $ 98,333 4,351 (475) 24,250
Beggining Balance (in shares) at Dec. 31, 2019   52,657,000      
Ending Balance at Dec. 31, 2020 205,283 $ 145,668 17,502 6,255 35,858
Ending Balance (in shares) at Dec. 31, 2020   66,912,000      
Beginning Balance at Jun. 30, 2020 138,731 $ 105,829 5,128 (547) 28,321
Beggining Balance (in shares) at Jun. 30, 2020   56,403,000      
Shares issued in public offering, net of issuance costs 35,275 $ 35,275      
Shares issued in pubic offering, net of issuance costs (in shares)   9,396,000      
Warrants issued in public offering 11,369   11,369    
Shares issued on exercise of stock options 129 $ 206 (77)    
Shares issued on exercise of stock options (in shares)   161,000      
Share-based compensation 472   472    
Cumulative translation adjustment 31     31  
Net income (loss) 520       520
Ending Balance at Sep. 30, 2020 186,527 $ 141,310 16,892 (516) 28,841
Ending Balance (in shares) at Sep. 30, 2020   65,960,000      
Beginning Balance at Dec. 31, 2020 205,283 $ 145,668 17,502 6,255 35,858
Beggining Balance (in shares) at Dec. 31, 2020   66,912,000      
Shares issued in public offering, net of issuance costs 127,489 $ 127,489      
Shares issued in pubic offering, net of issuance costs (in shares)   10,887,000      
Shares issued in acquisition 41,752 $ 41,752      
Shares issued in acquisition (in shares)   4,707,000      
Shares issued on exercise of warrants 18,495 $ 29,050 (10,555)    
Shares issued on exercise of warrants (in shares)   3,188,000      
Shares issued on exercise of stock options 199 $ 310 (111)    
Shares issued on exercise of stock options (in shares)   177,000      
Share re-purchases $ (5,000)   (5,000)    
Share re-purchases (in shares) (536,052) (535,000)      
Share-based compensation $ 5,705   5,705    
Share-based compensation (in shares)   370,000      
Cumulative translation adjustment 208     208  
Net income (loss) (11,154)       (11,154)
Ending Balance at Sep. 30, 2021 382,977 $ 344,269 7,541 6,463 24,704
Ending Balance (in shares) at Sep. 30, 2021   85,706,000      
Beginning Balance at Jun. 30, 2021 343,536 $ 302,497 6,748 10,332 23,959
Beggining Balance (in shares) at Jun. 30, 2021   80,964,000      
Shares issued in acquisition 41,752 $ 41,752      
Shares issued in acquisition (in shares)   4,707,000      
Shares issued on exercise of stock options 13 $ 20 (7)    
Shares issued on exercise of stock options (in shares)   15,000      
Share re-purchases (1,020)   (1,020)    
Share re-purchases (in shares)   (107,000)      
Share-based compensation 1,820   1,820    
Share-based compensation (in shares)   127,000      
Cumulative translation adjustment (3,869)     (3,869)  
Net income (loss) 745       745
Ending Balance at Sep. 30, 2021 $ 382,977 $ 344,269 $ 7,541 $ 6,463 $ 24,704
Ending Balance (in shares) at Sep. 30, 2021   85,706,000